Fabienne Hermitte

5PUBLICATIONS
24CO-AUTHORS
Tumour immunologyMolecular targetsCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 05, 2021
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.

James Spicer, Aurélien Marabelle, Jean-Francois Baurain

|Oct 24, 2020
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer.

Alessandro Ottaiano, Michele Caraglia, Annabella Di Mauro

|May 27, 2020
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer.

Frank A Sinicrope, Qian Shi, Fabienne Hermitte

Pageof 1